268 related articles for article (PubMed ID: 4744573)
1. Invited discussion: kinetic approach to the study of cell-mediated immunity in Hodgkin's disease.
Hersh EM
Natl Cancer Inst Monogr; 1973 May; 36():123-4. PubMed ID: 4744573
[No Abstract] [Full Text] [Related]
2. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
Levine PH; Reisher JI
Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
[No Abstract] [Full Text] [Related]
3. International Symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 4. Synthesis and epidemiological implications. Invited discussion: Synthesis and epidemiologic implications.
Miller RW
Natl Cancer Inst Monogr; 1973 May; 36():171-2. PubMed ID: 4270377
[No Abstract] [Full Text] [Related]
4. An overview of cancer immunology.
Ritts RE; Neel HB
Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
[No Abstract] [Full Text] [Related]
5. [Current immunologic data on Hodgkin's disease].
Weisgerber C; Kourilsky FM
Rev Prat; 1974 Oct; 24(45):3927-9. PubMed ID: 4445766
[No Abstract] [Full Text] [Related]
6. Impaired immunoresponsiveness in tumor patients.
Harris J; Copeland D
Ann N Y Acad Sci; 1974; 230():56-85. PubMed ID: 4595955
[No Abstract] [Full Text] [Related]
7. International symposium on Hodgkin's disease. Session I. Epidemiology and etiology. Part 3. Immunology. Introduction.
Good RA
Natl Cancer Inst Monogr; 1973 May; 36():93-4. PubMed ID: 4582999
[No Abstract] [Full Text] [Related]
8. Immunologic deficiency in Hodgkin's disease.
Sokal JE
Tumori; 1973; 59(5):343-50. PubMed ID: 4360756
[No Abstract] [Full Text] [Related]
9. [Immunologic deficit in Hodgkin's disease. Clinical reflections and pathogenetic implications].
Maggi E; Romagnani S; Ricci M
Ann Ital Med Int; 1986 Mar; 1(1):54-65. PubMed ID: 3079355
[No Abstract] [Full Text] [Related]
10. [Immunological competence in Hodgkin's disease].
Lang JM
Pathol Biol (Paris); 1973 Mar; 21(3):285-97. PubMed ID: 4145143
[No Abstract] [Full Text] [Related]
11. Effects of cancer on the immune globulins and immunity.
Fahey JL
Proc Natl Cancer Conf; 1964; 5():417-20. PubMed ID: 4159237
[No Abstract] [Full Text] [Related]
12. Immunodeficiency states.
Lessof MH
Proc R Soc Med; 1974 Jun; 67(6 Pt 2):530-6. PubMed ID: 4368789
[No Abstract] [Full Text] [Related]
13. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
Gupta S
Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
[TBL] [Abstract][Full Text] [Related]
14. Immune deficiency states associated with malignant disease in man.
Harris J; Bagai RC
Med Clin North Am; 1972 Mar; 56(2):501-14. PubMed ID: 4623010
[No Abstract] [Full Text] [Related]
15. 'Immune' RNA-mediated transfer of delayed skin reactivity in patients with Hodgkin's disease.
Han T
Clin Exp Immunol; 1973 Jun; 14(2):213-7. PubMed ID: 4717914
[TBL] [Abstract][Full Text] [Related]
16. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
Berceanu S; Gociu M
Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
[No Abstract] [Full Text] [Related]
17. [Clinical significance of the transfer factor].
Mutz I; Humphrey GB
Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
[No Abstract] [Full Text] [Related]
18. Immunity in Hodgkin's disease.
Leibowitz S
Guys Hosp Rep; 1966; 115(3):341-57. PubMed ID: 5334964
[No Abstract] [Full Text] [Related]
19. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
[No Abstract] [Full Text] [Related]
20. [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].
Ponzone A; Tarocco RP; Nicola P
Minerva Pediatr; 1970 Dec; 22(51):2542-60. PubMed ID: 4993895
[No Abstract] [Full Text] [Related]
[Next] [New Search]
